Both in Biotechnology
Allogene Therapeutics vs Surrozen
Over the past year ALLO returned −4.8% and SRZN returned +107.4%; their daily moves had a correlation of 0.14.
ALLO −4.8% SRZN +107.4%Growth of $1, one year, split-adjusted
| Metric | ALLO | SRZN |
|---|---|---|
| Price | $1.18 | $29.04 |
| Market cap | $407.7M | $341.3M |
| Today | −5.60% | −1.43% |
| 1 month | −23.4% | −3.2% |
| 6 months | −45.1% | −13.6% |
| Year to date | −13.9% | +28.5% |
| 1 year | −3.3% | +113.7% |
| Revenue growth (YoY) | — | +408.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −919.8% | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | 87.9× | 29.7× |
| Net cash | $332.6M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 53.4% | 174.0% |
| Short % of float | 19.4% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).